BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21500190)

  • 1. Epigenetic repression of regulator of G-protein signaling 2 promotes androgen-independent prostate cancer cell growth.
    Wolff DW; Xie Y; Deng C; Gatalica Z; Yang M; Wang B; Wang J; Lin MF; Abel PW; Tu Y
    Int J Cancer; 2012 Apr; 130(7):1521-31. PubMed ID: 21500190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulator of G-protein signaling 2 (RGS2) inhibits androgen-independent activation of androgen receptor in prostate cancer cells.
    Cao X; Qin J; Xie Y; Khan O; Dowd F; Scofield M; Lin MF; Tu Y
    Oncogene; 2006 Jun; 25(26):3719-34. PubMed ID: 16449965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression to metastatic stage in a cellular model of prostate cancer is associated with methylation of the androgen receptor gene and transcriptional suppression of the insulin-like growth factor-I receptor gene.
    Schayek H; Bentov I; Sun S; Plymate SR; Werner H
    Exp Cell Res; 2010 May; 316(9):1479-88. PubMed ID: 20338164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis.
    Tian J; Lee SO; Liang L; Luo J; Huang CK; Li L; Niu Y; Chang C
    J Biol Chem; 2012 Nov; 287(47):39954-66. PubMed ID: 23012352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitization of androgen refractory prostate cancer cells to anti-androgens through re-expression of epigenetically repressed androgen receptor - Synergistic action of quercetin and curcumin.
    Sharma V; Kumar L; Mohanty SK; Maikhuri JP; Rajender S; Gupta G
    Mol Cell Endocrinol; 2016 Aug; 431():12-23. PubMed ID: 27132804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demethylation of the miR-146a promoter by 5-Aza-2'-deoxycytidine correlates with delayed progression of castration-resistant prostate cancer.
    Wang X; Gao H; Ren L; Gu J; Zhang Y; Zhang Y
    BMC Cancer; 2014 May; 14():308. PubMed ID: 24885368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of the PMEPA1 gene, a negative regulator of the androgen receptor in prostate cancer.
    Sharad S; Ravindranath L; Haffner MC; Li H; Yan W; Sesterhenn IA; Chen Y; Ali A; Srinivasan A; McLeod DG; Yegnasubramanian S; Srivastava S; Dobi A; Petrovics G
    Epigenetics; 2014 Jun; 9(6):918-27. PubMed ID: 24694733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of histone deacetylase and DNA methyltransferase inhibitors on the expression of the androgen receptor gene in androgen-independent prostate cancer cell lines.
    Fialova B; Smesny Trtkova K; Paskova L; Langova K; Kolar Z
    Oncol Rep; 2013 May; 29(5):2039-45. PubMed ID: 23503510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells.
    Jarrard DF; Kinoshita H; Shi Y; Sandefur C; Hoff D; Meisner LF; Chang C; Herman JG; Isaacs WB; Nassif N
    Cancer Res; 1998 Dec; 58(23):5310-4. PubMed ID: 9850055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of RGS2 (Regulator of G-protein signaling 2) in chemoresistant ovarian cancer cells.
    Cacan E
    J Chemother; 2017 Jun; 29(3):173-178. PubMed ID: 28102109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RGS2 is prognostic for development of castration resistance and cancer-specific survival in castration-resistant prostate cancer.
    Linder A; Larsson K; Welén K; Damber JE
    Prostate; 2020 Aug; 80(11):799-810. PubMed ID: 32449815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation of androgen receptor gene expression in human prostate cancers.
    Nakayama T; Watanabe M; Suzuki H; Toyota M; Sekita N; Hirokawa Y; Mizokami A; Ito H; Yatani R; Shiraishi T
    Lab Invest; 2000 Dec; 80(12):1789-96. PubMed ID: 11140692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor is negatively correlated with the methylation-mediated transcriptional repression of miR-375 in human prostate cancer cells.
    Chu M; Chang Y; Li P; Guo Y; Zhang K; Gao W
    Oncol Rep; 2014 Jan; 31(1):34-40. PubMed ID: 24173286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic repression of regulator of G-protein signaling 2 by ubiquitin-like with PHD and ring-finger domain 1 promotes bladder cancer progression.
    Ying L; Lin J; Qiu F; Cao M; Chen H; Liu Z; Huang Y
    FEBS J; 2015 Jan; 282(1):174-82. PubMed ID: 25323766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of androgen receptor coregulator MAGE-11 in prostate cancer by DNA hypomethylation and cyclic AMP.
    Karpf AR; Bai S; James SR; Mohler JL; Wilson EM
    Mol Cancer Res; 2009 Apr; 7(4):523-35. PubMed ID: 19372581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prostatic environment suppresses growth of androgen-independent prostate cancer xenografts: an effect influenced by testosterone.
    Jennbacken K; Gustavsson H; Tesan T; Horn M; Vallbo C; Welén K; Damber JE
    Prostate; 2009 Aug; 69(11):1164-75. PubMed ID: 19399749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth.
    Deng X; Shao G; Zhang HT; Li C; Zhang D; Cheng L; Elzey BD; Pili R; Ratliff TL; Huang J; Hu CD
    Oncogene; 2017 Mar; 36(9):1223-1231. PubMed ID: 27546619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor.
    Kasina S; Macoska JA
    Mol Cell Endocrinol; 2012 Apr; 351(2):249-63. PubMed ID: 22245379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancer.
    Takayama K; Horie-Inoue K; Suzuki T; Urano T; Ikeda K; Fujimura T; Takahashi S; Homma Y; Ouchi Y; Inoue S
    Mol Endocrinol; 2012 May; 26(5):748-61. PubMed ID: 22456197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paired box 2 upregulates androgen receptor gene expression in androgen-independent prostate cancer.
    Ito S; Ueda T; Ueno A; Nakagawa H; Taniguchi H; Hongo F; Kamoi K; Okihara K; Kawauchi A; Miki T
    FEBS J; 2014 Oct; 281(19):4506-18. PubMed ID: 25132193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.